The general goal of the proposed research is to understand how cancer associated stroma, including cancer associated fibroblast (CAF), tumor infiltrating lymphocytes (TIL) and their interactions with carcinoma cells contributes to pulmonary metastasis of breast cancer. CAF and TIL are critically involved in mammary tumorigenesis and metastasis. To address the role of CAF and TIL in pulmonary metastasis of mammary cancer, we have established several spontaneous and transplant mammary tumor models. Our research demonstrates that receptor for activated nuclear factor ?B ligand (RANKL) is expressed by tumor infiltrating CD4+ T cells, mainly Treg cells in tumor associated stroma. RANKL activates its cognate receptor RANK on cell surface of carcinoma cells, which leads to the activation and nuclear translocation of IKK? and in turn the repression of maspin, a key metastasis inhibitor in a variety of cancers. However, the links between carcinoma cells, CAF, and CD4+CD25+ T cells still remain obscure. I therefore propose to pursue the following aims: Identify other factors from CAFs responsible for Treg cell infiltration into tumor;Identify signaling pathway that controls chemokine expression from CAF; Examine the role of carcinoma cells in fibroblast activation;Examine the role of alternative NF-?B pathways components, including NF-?B inducing kinase (NIK), TRAF2, and TRAF3 in ErbB2-induced mammary tumor development and metastasis;and identify upstream members, if other than RANKL that activates NIK/IKK? during mammary tumorigenesis. The proposed studies are innovative as they address a poorly explored and controversial research problem with great clinical significance and public health importance.

Public Health Relevance

Breast cancer is second common malignancy and the leading cause of cancer-related mortality amongst women in the US, mainly caused by metastatic spread of advanced tumors to bone, lung, brain and liver. This proposal will focus on the interplays between tumor associated stoma, mainly CAFs, and tumor-infiltrating T cells and carcinoma cells. This proposed study should shed light on the understanding of fundamental role of inflammatory signals in pulmonary metastasis and reveal potential targets of great importance leading to the cure for mammary cancer metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Transition Award (R00)
Project #
5R00CA158055-03
Application #
8523028
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mohla, Suresh
Project Start
2012-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
3
Fiscal Year
2013
Total Cost
$230,569
Indirect Cost
$77,874
Name
University of Iowa
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Cyr, A R; Kulak, M V; Park, J M et al. (2015) TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene 34:436-44
Borcherding, Nicholas; Kusner, David; Liu, Guang-Hui et al. (2014) ROR1, an embryonic protein with an emerging role in cancer biology. Protein Cell 5:496-502
Guan, D; Zhang, W; Zhang, W et al. (2013) Switching cell fate, ncRNAs coming to play. Cell Death Dis 4:e464